Market Place
Sourcing Support
All News #Library
Biotech
Spinogenix Launches Phase 2B/3 Trial Of SPG601 For Fragile X
23 Apr 2026 //
PR NEWSWIRE
Spinogenix`s SPG601 Proves Effective in Fragile X Study
09 Apr 2026 //
PR NEWSWIRE
Spinogenix Shows Positive Phase 2 Results For Tazbentetol
26 Mar 2026 //
PR NEWSWIRE
Spinogenix Wraps Phase 2 Trial Enrollment For Tazbentetol
11 Mar 2026 //
PR NEWSWIRE
Spinogenix Shows Fast, Lasting Cognitive Boost In Alzheimer
08 Dec 2025 //
PR NEWSWIRE
Spinogenix Unveils Phase 2A Results For SPG302, In ALS
04 Nov 2025 //
PR NEWSWIRE
Spinogenix To Unveil SPG601, Phase 2A Trial Results For Fragile X
23 Oct 2025 //
PR NEWSWIRE
Spinogenix Reveals Spg302`s Neuroprotective Effects In Glaucoma
16 Oct 2025 //
PR NEWSWIRE
Spinogenix Completes Ph 2 Enrollment for Alzheimer’s Drug
24 Jun 2025 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.